Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP173729.RAR0GSvouewVRODw9XU6CbPC3quufmVeJityRO2T6cw-c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP173729.RAR0GSvouewVRODw9XU6CbPC3quufmVeJityRO2T6cw-c130_assertion type Assertion NP173729.RAR0GSvouewVRODw9XU6CbPC3quufmVeJityRO2T6cw-c130_head.
- NP173729.RAR0GSvouewVRODw9XU6CbPC3quufmVeJityRO2T6cw-c130_assertion wasGeneratedBy ECO_0000203 NP173729.RAR0GSvouewVRODw9XU6CbPC3quufmVeJityRO2T6cw-c130_provenance.
- NP173729.RAR0GSvouewVRODw9XU6CbPC3quufmVeJityRO2T6cw-c130_assertion wasDerivedFrom befree-20140225 NP173729.RAR0GSvouewVRODw9XU6CbPC3quufmVeJityRO2T6cw-c130_provenance.
- NP173729.RAR0GSvouewVRODw9XU6CbPC3quufmVeJityRO2T6cw-c130_assertion SIO_000772 20308656 NP173729.RAR0GSvouewVRODw9XU6CbPC3quufmVeJityRO2T6cw-c130_provenance.
- NP173729.RAR0GSvouewVRODw9XU6CbPC3quufmVeJityRO2T6cw-c130_assertion evidence source_evidence_literature NP173729.RAR0GSvouewVRODw9XU6CbPC3quufmVeJityRO2T6cw-c130_provenance.
- NP173729.RAR0GSvouewVRODw9XU6CbPC3quufmVeJityRO2T6cw-c130_assertion description "[This adverse prognostic impact was more pronounced in the intermediate cytogenetic risk group (EFS; HR, 1.64; P < .001; and RFS; HR, 1.55; P = .02), and was also apparent in cytogenetically normal AML (EFS; HR, 1.67; P = .008).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP173729.RAR0GSvouewVRODw9XU6CbPC3quufmVeJityRO2T6cw-c130_provenance.